跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Dutasteride/Tadalafil
首页
药物
Dutasteride/Tadalafil
Dutasteride/Tadalafil
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
PHARMACEUTICAL COMPOSITION COMPRISING TADALAFIL OR PHARMACEUTICALLLY ACCEPTABLE SALT THEREOF AND DUTASTERIDE OR PHARMACEUTICALLLY ACCEPTABLE SALT THEREOF EXHIBITING NOVEL DISSOLUTION RATE
US 2024075028 A1
申请人: DONG KOOK PHARM CO LTD
优先权: 2020
CN
EP
US
WO
5 件公开
TADALAFIL ORAL SUSPENSION
EP 4422599 B1
申请人: FARMALIDER SA
优先权: 2021
CN
EP
US
WO
4 件公开
COMPOSITE FORMULATION OF DUTASTERIDE AND TADALAFIL COMPRISING GLYCEROL FATTY ACID ESTER DERIVATIVE OR PROPYLENE GLYCOL FATTY ACID ESTER DERIVATIVE AND ORAL CAPSULE FORMULATION COMPRISING SAME
CN 109310643 A
申请人: YUYU PHARMA INC
优先权: 2016
CN
ORAL CAPSULE COMPOSITE FORMULATION OF DUTASTERIDE AND TADALAFIL
CN 109843272 A
申请人: YUYU PHARMA INC
优先权: 2016
CN
Dutasteride compound, preparation method thereof, dutasteride and tadalafil compound preparation, and preparation method and application of dutasteride and tadalafil compound preparation
CN 120501751 A
申请人: HUNAN JIUWEI BIOLOGICAL MEDICINE CO LTD
优先权: 2025
CN
药物
反馈